Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
暂无分享,去创建一个
S. Bielack | C. Blattmann | M. Nathrath | C. Vokuhl | M. Scheer | T. Holl | T. Kalle | T. von Kalle | S. Stegmaier | M. Cox | M. Reynolds | U. Klenk | R. Tupper | K. Simon-Klingenstein | K. Apel | R. Jenewein | P. Klothaki | P. Müller-Abt | S. Ortega-Lawerenz